Covington Capital Management’s Insmed INSM Stock Holding History

Covington Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,000	Closed	-$62K	–	817
2017 Q3	$62K	Buy	+2,000	New	+$38.1K	﹤0.01%	406

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Covington Capital Management's INSM Position: Q4 2017 in Review

Covington Capital Management sold out of Insmed (INSM) in Q4 2017, closing a stake of 2,000 shares — an estimated $62K sold.

Covington Capital Management first reported a position in INSM in Q3 2017 and held it in 1 quarter. The position peaked at $62K in Q3 2017. 129 funds tracked by Wall St. Rank hold INSM as of Q4 2017.

Covington Capital Management reported no remaining Insmed position as of Q4 2017 after selling out during the quarter.
Covington Capital Management sold 2,000 Insmed shares in Q4 2017, an estimated $62K.
Covington Capital Management first reported a position in Insmed in Q3 2017 and held it in 1 quarter.
Covington Capital Management's Insmed position peaked at $62K in Q3 2017.
129 funds tracked by Wall St. Rank held Insmed as of Q4 2017.

Based on Covington Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.